Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Apyx Medical (APYX) Operating Expenses (2016 - 2026)

Apyx Medical filings provide 15 years of Operating Expenses readings, the most recent being $12.0 million for Q4 2025.

  • On a quarterly basis, Operating Expenses changed 0.2% to $12.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $39.5 million, a 18.08% decrease, with the full-year FY2025 number at $39.5 million, down 18.08% from a year prior.
  • Operating Expenses hit $12.0 million in Q4 2025 for Apyx Medical, up from $9.1 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $14.7 million in Q4 2023 to a low of $8.7 million in Q1 2025.
  • Median Operating Expenses over the past 5 years was $12.3 million (2021), compared with a mean of $12.1 million.
  • Biggest five-year swings in Operating Expenses: soared 41.92% in 2021 and later plummeted 30.63% in 2025.
  • Apyx Medical's Operating Expenses stood at $13.8 million in 2021, then grew by 2.39% to $14.2 million in 2022, then grew by 3.68% to $14.7 million in 2023, then fell by 18.26% to $12.0 million in 2024, then decreased by 0.2% to $12.0 million in 2025.
  • The last three reported values for Operating Expenses were $12.0 million (Q4 2025), $9.1 million (Q3 2025), and $9.7 million (Q2 2025) per Business Quant data.